Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement217 K-56.48 M-173.98 M-200.41 M-574.82 M173.91 M7.51 MFlux de trésorerie liés aux activités de financement114.57 M252.68 M121.96 M388.94 M1.01 B40.61 M426.05 MFlux de trésorerie disponible-62.03 M-88.59 M-115.2 M-166.31 M-225.97 M-383.68 M-419.52 M
Crinetics Pharmaceuticals, Inc. - Common Stock
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.